William Brown

Founder, CEO and Managing Partner

Adam Eagleston

Chief Investment Officer

2 past transactions

Owl's Brew

Series A in 2021
Owl's Brew, founded in 2013 by tea sommelier Jennie Ripps and Maria Littlefield, specializes in all-natural, loose leaf tea blends crafted in New York City. The company offers two primary product lines: Owl's Brew Mixer, a selection of tea-based craft cocktail mixers, and Owl's Brew Boozy Tea, which combines brewed tea with alcohol. The beverages are made from whole tea leaves, fruits, spices, and herbs, ensuring that no artificial flavors are added. This commitment to quality allows consumers to enjoy a variety of flavored tea products that are both refreshing and unique.

Imbed Biosciences

Series A in 2019
Imbed Biosciences, Inc. is a medical device company based in Madison, Wisconsin, focused on developing innovative technologies for embedding bioactive molecules in wound dressings and surgical implants. The company specializes in antibacterial silver nanofilms that facilitate the sustained release of non-toxic silver, offering effective wound care for extended periods. By utilizing its advanced biomaterials platforms, Imbed aims to enhance wound dressings to prevent infections and promote faster healing, addressing a significant market opportunity in the management of surgical and chronic wounds, valued at $3 billion in the U.S. and Europe. Founded in 2010 as a spin-off from the University of Wisconsin-Madison, Imbed is backed by extensive research and a team with over 25 years of collective experience in clinical wound management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.